SCHEMBL23240263

SCHEMBL23240263

Cc1cc(C(C)(C)O)n(C2CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
TGFBR1 P36897 3/20 0.35
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KCNJ6 P48051 4/20 0.32
KCNJ3 P48549 4/20 0.32
KCNJ5 P48544 3/20 0.32
CYP19A1 P11511 2/20 0.32
CYP11B1 P15538 2/20 0.32
CYP11B2 P19099 2/20 0.32
ADRB1 P08588 1/20 0.30
ADRA2A P08913 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23213976 0.81
SCHEMBL19953968 0.79 KDM4E (0.39) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL25745817 0.79 KDM4E (0.42) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL25745828 0.77 KDM4E (0.44) KDM4EALDH1A1HSD17B10KCNJ6KCNJ3
SCHEMBL25745806 0.76 KDM4E (0.40) KDM4EALDH1A1HSD17B10KCNJ6KCNJ3
SCHEMBL19953969 0.75 TGFBR1 (0.40) DRD2DRD4DRD3TGFBR1KCNJ6
SCHEMBL19953971 0.75 TRPV4 (0.41) DRD2DRD4DRD3ALDH1A1HSD17B10
SCHEMBL15935405 0.72 SMN1; SMN2 (0.41) DRD2DRD4DRD3KDM4EALDH1A1
SCHEMBL25745827 0.72 DRD2 (0.41) DRD2DRD4DRD3ALDH1A1ADRA2A
SCHEMBL24815007 0.71 DRD2 (0.41) DRD2DRD4DRD3TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021070132-A1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2021-04-15 WO disclosed